In a recent study published in Emerging Infectious Diseases, researchers observed early recurrence of coronavirus disease 2019 (COVID-19). Study: Reinfections with Different SARS-CoV-2 Omicron ...

In a recent study posted to the bioRxiv* preprint server, researchers comparatively evaluated the neutralization antibody (Ab) titers for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ...

University of Arizona has identified non-structural protein 3 (nsp3; PL-pro) (SARS-CoV-2; COVID-19 virus) inhibitors reported to be useful for the treatment of SARS-CoV-2 infection (COVID-19).

Investigators determined that the BA.2 subvariant is less severe than the previous Delta variant and less severe to an even greater extent than the original Omicron variant In an analysis of COVID-19 ...

Rockefeller University has disclosed non-structural protein 3 (nsp3; PL-PRO) (SARS-CoV-2; COVID-19 virus) inhibitors reported to be useful for the treatment of SARS-CoV-2 infection (COVID-19).